| Financial Year |
March 31 2023 |
| Monetary Funds |
21,809,165,904.93 |
| Held-for-trading Financial Assets |
231,607,395.14 |
| Notes Receivable |
937,448,026.30 |
| Accounts Receivable |
9,857,715,595.15 |
| Advances to Suppliers |
331,606,636.86 |
| Other Receivables |
303,002,866.33 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,528,756,501.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
58,210,136.75 |
| Other Current Assets |
1,571,535,095.74 |
| Total Current Assets |
45,077,458,911.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
278,607,057.50 |
| Long-term Equity Investment |
589,965,362.99 |
| Investment Properties |
-- |
| Fixed Assetes |
12,239,951,903.97 |
| Under-construction Projects |
8,621,214,307.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
640,416,294.38 |
| R&D expenses |
-- |
| Goodwill |
70,728,600.15 |
| Long-Term Deferred and Prepaid Expenses |
3,598,607,432.69 |
| Deferred Income Tax Assets |
800,202,957.85 |
| Other Non-Current Assets |
1,401,014,757.13 |
| Sub-Total of Non-Current Assets |
31,364,086,460.61 |
| Total Assets |
76,441,545,372.24 |
| Short-Term Loans |
9,505,084,371.35 |
| Trading Financial liabilities |
1,194,000,000.00 |
| Notes Payable |
8,009,540,352.90 |
| Accounts Payable |
12,634,464,989.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
851,415,465.82 |
| Taxes Payable |
73,128,784.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
467,645,068.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,974,402,843.22 |
| Other Current Liabilities |
1,304,336,732.96 |
| Sub-Total of Current Liabilities |
37,765,819,284.01 |
| Long-term Loans |
6,172,508,254.20 |
| Bonds Payable |
389,936,653.96 |
| Long-Term Accounts Payable |
1,955,552,397.89 |
| Special Payable |
-- |
| Estimatied Liabilities |
433,121,424.23 |
| Deferred Income Tax Liabilities |
201,783,889.78 |
| Other Non-Current Liabilities |
673,172,781.51 |
| Sub-Total of Non-Current Liabilities |
12,152,655,130.58 |
| Total Liabilities |
49,918,474,414.59 |
| Paid-In Capital(Or Share Stock) |
1,862,319,056.00 |
| Capital Surplus |
13,374,051,801.05 |
| Surplus Reserve |
787,985,861.10 |
| LESS:Treasury Stock |
105,457,094.70 |
| Undistributed Profits |
4,080,017,959.89 |
| Minority Stockholder's Interest |
6,519,633,077.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,003,437,879.96 |
| Owner's Equity（Stockholder's Equity） |
26,523,070,957.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
76,441,545,372.24 |
